CatalYm Appoints Peter Garcia as Chief Financial Officer

CatalYm Appoints Peter Garcia as Chief Financial Officer   Munich, Germany and...

Read More

CatalYm Appoints Christian S. Schade as Chairman of the Board of Directors

CatalYm Appoints Christian S. Schade as Chairman of the Board of Directors...

Read More

CatalYm Advances Visugromab into Phase 2/3 Development for Cancer Cachexia with First Patient Dosed

CatalYm Advances Visugromab into Phase 2/3 Development for Cancer Cachexia with First...

Read More

CatalYm Doses First Patient in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as Second-Line Treatment in Unresectable/Metastatic Hepatocellular Carcinoma

CatalYm Doses First Patient in Phase 2b Trial Evaluating Visugromab in Combination...

Read More